查詢結果分析
相關文獻
- Radical Resection and Intraoperative Radiotherapy for a Recurrent Endometrial Cancer after Prolonged Remission Following Aggressive Salvage Therapy: Case Report
- Donor Leukocyte Infusion as Salvage Therapy in an Adult with Relapsed Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation
- 淺論乳癌手術中放射治療
- 術中放射治療於早期乳癌病患的應用與現況
- Pemetrexed Followed by Docetaxel or a Reverse Sequence in Non-Small-Cell Lung Cancer
- 復發性子宮內膜癌之手術治療
- 手術中放射治療設備IntraBeam®接收測試報告
- Sofosbuvir/Velpatasvir/Voxilaprevir:C肝救援治療新選擇
頁籤選單縮合
題 名 | Radical Resection and Intraoperative Radiotherapy for a Recurrent Endometrial Cancer after Prolonged Remission Following Aggressive Salvage Therapy: Case Report=根治性切除合併術中放射治療用於子宮內膜癌初復發救援治療後長期緩解之再度復發:病例報告 |
---|---|
作 者 | 黃慧君; 賴瓊慧; 蔡介生; 吳冠群; 林政道; | 書刊名 | 長庚醫學 |
卷 期 | 22:4 1999.12[民88.12] |
頁 次 | 頁654-659 |
分類號 | 417.27 |
關鍵詞 | 復發性子宮內膜癌; 救援治療; 術中放射治療; Recurrent endometrial cancer; Salvage therapy; Intraoperative radiotherapy; (IORT); |
語 文 | 英文(English) |
中文摘要 | 復發性子宮內膜癌除了單純在陰道再發者之外預後是很差的。本篇報告一名子宮 內膜癌復發的病例。一位58歲婦人最初接受了子宮全切除手術合併兩側卵巢、輸卵管、主動 脈旁及骨盆腔淋巴節摘除。術後7個月,第一次復發於左側骨盆處,救援治療包括放射線及 荷爾蒙(tamoxifen及megace)治療,疾病完全緩解後數月,腫瘤指標CA-125又逐漸升高,因 此病人接受了六個療程的化學治療(cisplatin及adriamycin)。CA-125指數始終在l00U/ml 上下浮動一直到第一次救援治療後75個月,終於證實腫瘤又再度復發於左側腸骨凹處。第二 次的救援治療包括腫瘤根治性切除合併術中放射治療並於術後追加四個療程的化學治療 (paclitaxe)及carboplatin),各項臨床檢查及腫瘤指標皆回復正常,疾病再度獲得完全的 緩解,自第二次復發後,病人於臨床上證實疾病緩解已達2年。由此病例我們發現,(復發性) 子宮內膜癌即使在救援治療後獲得長時間緩解,再度復發仍然是可能的,但即使二度再發仍 可經積極的救援治療而再度控制。在局部復發或再度復發的子宮內膜癌,結合多元化治療方 案,如根治性切除合併術中放射治療並於術後執行以paclitaxel為主劑的化學治療,即使以 前使用過cisplatin為主劑的化學治療及骨盆放射治療的病例仍是可行的。 |
英文摘要 | The prognosis of recurrent endometrial carcinomas is generally poor, except for isolated vaginal relapse. We report a case of recurrent endometrial cancer in a 58-year-old woman who initially received a type I extended hysterectomy with bilateral salpin-go-oophorectomy and bilateral para-aortic and pelvic lymph node dissection. The first recurrence occurred in the left parametrium 7 months after the primary surgery. The salvage therapy consisted of radiotherapy combined with hormonal therapy (tamoxifen and Megace). Complete remission was achieved initially. Subsequently, the patient accepted six courses of chemotherapy (cisplatin and Adriamycin) for progressive elevation of cancer antigen 125 (CA-125). The CA-125 levels remained elevated with titerst fluctuating around 100 U/ml until a second recurrence at the left iliac 75 months following salvage therapy. The second salvage treatment consisted of maximal debulking of the pelvic mass and intraoperative radiotherapy (IORT) followed by four courses of chemotherapy with paclitaxel and carboplatin. Complete remission was again accomplished, with clinical investigations and molecular markers returning to normal. The patient has been clinically free of disease for more than 2 years since the second relapse of cancer. In this particular case, we found that repeated recurrence could occur after a long complete remission following salvage therapy; however, the disease could be recontrolled with further aggressive salvage efforts. A multimodality approach with combinations of radical resection, IORT, and paclitaxel-based chemotherapy can be offered to patients with localized recurrent or repeatedly recurrent endometrial carcinoma after previous cisplatin-based chemotherapy and pelvic radiation. |
本系統中英文摘要資訊取自各篇刊載內容。